Clinical Trial Update: Semaglutide vs Sitagliptin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing semaglutide and sitagliptin in liver transplant recipients with diabetes and fatty liver disease. Enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Sitagliptin (sitagliptin)
• semaglutide (semaglutide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Liver Transplant; Complications, Diabetes Mellitus | Phase 4 | Status: ENROLLING_BY_INVITATION